Search

Search Constraints

You searched for: Author/Creator Byers, Frank W.

Search Results

1. Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides. Issue 23 (1st December 2017)

2. Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides. Issue 13 (1st July 2017)

3. Corrigendum to "Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides" [Bioorg. Med. Chem. Lett. 27(23) (2017) 5179–5184]. Issue 17 (15th September 2018)

4. Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5. Issue 10 (1st June 2018)

5. Discovery of imidazo[1, 2-a]-, [1, 2, 4]triazolo[4, 3-a]-, and [1, 2, 4]triazolo[1, 5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5. Issue 21 (1st November 2017)

6. Further optimization of the M5 NAM MLPCN probe ML375: Tactics and challenges. Issue 3 (1st February 2015)

7. N-Alkylpyrido[1′, 2′:1, 5]pyrazolo-[4, 3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents. Issue 8 (15th April 2016)

8. Optimization of M4 positive allosteric modulators (PAMs): The discovery of VU0476406, a non-human primate in vivo tool compound for translational pharmacology. Issue 11 (1st June 2017)